[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100432132":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":27,"centralContacts":31,"locations":36,"responsibleParty":55,"collaborators":57,"id":60,"slug":61,"hasResults":62,"nctId":63,"briefTitle":64,"officialTitle":64,"acronym":23,"eligibilityCriteria":65,"healthyVolunteers":66,"sex":67,"minAge":68,"maxAge":69,"enrollmentInfo":70,"targetDuration":23,"studyType":73,"phases":74,"briefSummary":76,"conditions":77,"keywords":79,"overallStatus":38,"whyStopped":23,"lastUpdateSubmitDate":81,"lastUpdatePostDateStruct":82,"startDateStruct":85,"completionDateStruct":87,"leadSponsor":89,"locationsCount":90},{"fullName":5,"class":6},"Florida International University","OTHER",[8,15],{"label":9,"type":10,"description":11,"interventionNames":12},"Preferred ENDS","EXPERIMENTAL","All participants will complete a lab visit where they will use their preferred ENDS ad libitum for up to 60 minutes",[13,14],"Other: Preferred ENDS","Other: Preferred ENDS with HWL",{"label":16,"type":10,"description":17,"interventionNames":18},"Preferred ENDS with HWL","All participants will complete a lab visit where they will use their preferred ENDS with a HWL on the device ad libitum for up to 60 minutes",[13,14],[20,24],{"type":6,"name":9,"description":21,"armGroupLabels":22,"otherNames":23},"Preferred ENDS without HWL on device",[9,16],null,{"type":6,"name":16,"description":25,"armGroupLabels":26,"otherNames":23},"Preferred ENDS with a HWL on device",[9,16],[28],{"name":29,"affiliation":5,"role":30},"Wasim Maziak, MD, PhD","PRINCIPAL_INVESTIGATOR",[32],{"name":29,"role":33,"phone":34,"phoneExt":23,"email":35},"CONTACT","305-348-4501","wmaziak@fiu.edu",[37],{"facility":5,"status":38,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"RECRUITING","Miami","Florida","33199","United States","US",{"type":45,"coordinates":46},"Point",[47,48],-80.19366,25.77427,{"lat":48,"lon":47},[51],{"name":52,"role":33,"phone":53,"phoneExt":23,"email":54},"Katherine Pita, BSN","786-209-9642","kmpita@fiu.edu",{"type":30,"investigatorFullName":29,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":23,"oldOrganization":23},"Professor, Department of Epidemiology",[58],{"name":59,"class":6},"University of Miami","100432132","developing-and-testing-health-warning-labels-on-the-ends-device-100432132",false,"NCT04907136","Developing and Testing Health Warning Labels on the ENDS Device","Inclusion Criteria:\n\n* Generally healthy individuals (determined by physical examination).\n* Age of 21-35 years.\n* Is willing to provide informed consent.\n* Is willing to attend the lab as required by the study protocol.\n* ENDS users (defined as using ENDS either daily or occasionally in the past 30 days)\n* Have abstained from ENDS use for 12 hours prior to each session.\n\nExclusion Criteria:\n\n* Report smoking cigarettes regularly (\\> 5 cigarettes\u002Fmonth in the past year).\n* Report regular use of any other tobacco\u002Fnicotine product (e.g., e-cig, pipes, cigars) in the past year.\n* Women who are breast-feeding or test positive for pregnancy (by urinalysis at screening).\n* Individuals with self-reported history of chronic disease or psychiatric conditions.\n* Individuals with history of or active cardiovascular disease, low or high blood pressure, seizures, and regular use of prescription medications (other than vitamins or birth control).\n* Individuals that report the use of non-commercial (i.e., street) e-cigarette liquid or products\n* Individuals that report current EVALI or COVID-19 related symptoms (i.e., cough, shortness of breath, chest pain, nausea, vomiting, abdominal pain, diarrhea, fever, chills, or weight loss)\n* Individuals that have or have been exposed to COVID-19 in the last 14 days.",true,"ALL","21 Years","35 Years",{"count":71,"type":72},80,"ESTIMATED","INTERVENTIONAL",[75],"NA","In this project, after systematically developing electronic nicotine delivery systems (ENDS) pictorial health warning labels (HWLs), a proven clinical lab model will be used to examine and test their effect when these are placed on the ENDS device on a variety of subjective (e.g. satisfaction, harm perception, nicotine dependence, intention to quit) and objective outcomes (e.g. plasma nicotine, puff topography) in young adults.",[78],"Electronic Cigarette Use",[80],"Health Warning Labels","2026-06-04",{"date":83,"type":84},"2026-06-05","ACTUAL",{"date":86,"type":84},"2023-12-13",{"date":88,"type":72},"2027-04-30",{"name":5,"class":6},1]